Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ocugen (OCGN) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Ocugen (OCGN) over the last 12 years, with Q3 2025 value amounting to -$18.7 million.

  • Ocugen's Consolidated Net Income fell 4441.45% to -$18.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$62.8 million, marking a year-over-year decrease of 2158.03%. This contributed to the annual value of -$54.8 million for FY2024, which is 1644.11% up from last year.
  • Latest data reveals that Ocugen reported Consolidated Net Income of -$18.7 million as of Q3 2025, which was down 4441.45% from -$14.9 million recorded in Q2 2025.
  • In the past 5 years, Ocugen's Consolidated Net Income ranged from a high of -$7.1 million in Q1 2021 and a low of -$25.6 million during Q2 2021
  • Over the past 5 years, Ocugen's median Consolidated Net Income value was -$15.3 million (recorded in 2024), while the average stood at -$16.4 million.
  • Its Consolidated Net Income has fluctuated over the past 5 years, first crashed by 60890.98% in 2021, then soared by 4746.8% in 2023.
  • Ocugen's Consolidated Net Income (Quarter) stood at -$14.6 million in 2021, then tumbled by 50.46% to -$21.9 million in 2022, then soared by 47.47% to -$11.5 million in 2023, then decreased by 20.09% to -$13.8 million in 2024, then plummeted by 35.35% to -$18.7 million in 2025.
  • Its Consolidated Net Income stands at -$18.7 million for Q3 2025, versus -$14.9 million for Q2 2025 and -$15.4 million for Q1 2025.